Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma

Background: The MENSA trial assessed the efficacy and safety of mepolizumab in patients with severe eosinophilic asthma. This report describes the efficacy and safety of mepolizumab in Japanese patients from MENSA. Methods: A post hoc analysis of the Japanese subgroup from the randomized, double-bli...

Full description

Bibliographic Details
Main Authors: Terufumi Shimoda, Hiroshi Odajima, Arisa Okamasa, Minako Kawase, Masaki Komatsubara, Bhabita Mayer, Steven Yancey, Hector Ortega
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893016301757